Hospira Oxaliplatin Injection 100 mg/20 mL vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

oxaliplatin, Quantity: 5 mg/mL

Disponible depuis:

Hospira Australia Pty Ltd

DCI (Dénomination commune internationale):

Oxaliplatin

forme pharmaceutique:

Injection, intravenous infusion

Composition:

Excipient Ingredients: tartaric acid; sodium hydroxide; water for injections

Mode d'administration:

Intravenous

Unités en paquet:

1 x 20 mL

classe:

Medicine Listed (Export Only)

Type d'ordonnance:

(S1) This Schedule is intentionally blank

indications thérapeutiques:

Oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin is indicated for: * Adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumour * Treatment of advanced colorectal cancer.

Descriptif du produit:

Visual Identification: Clear colourless solution practically free of particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store between 20 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2013-03-25